SGHT (SGHT) Stock Price & Analysis
SGHT (SGHT) fell 0.36% to USD 8.35 as of September 8, 2026 at 05:05 UTC, according to Nexqual real-time market data.
SGHT last closed at USD 8.35; the session ranged USD 8.14–8.45 on volume of 102,466 shares. Market capitalization is —, with a 52-week range of USD 3.19–9.24 (NMS). Source: Nexqual, September 8, 2026 at 05:05 UTC.
Key Statistics (as of September 8, 2026 at 05:05 UTC)
| Price | USD 8.35 |
|---|---|
| Change | ▼ 0.36% (down) |
| Previous Close | USD 8.35 |
| Open | USD 8.35 |
| Day Range | USD 8.14 – 8.45 |
| 52-Week Range | USD 3.19 – 9.24 |
| Volume | 102,466 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (SGHT)
Nexqual's technical model rates SGHT "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 05:05 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 68.84 (neutral) |
| vs SMA50 | Above (USD 6.56) |
| MACD | 0.54 (positive) |
From SGHT's Latest SEC 10-K Filing (filed 2026-03-04)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CTKB | Cytek Biosciences, Inc. | USD 4.7 | ▲ 0.21% |
| TMCI | Treace Medical Concepts, Inc. | USD 4.81 | ▲ 2.34% |
| RPID | Rapid Micro Biosystems, Inc. | USD 1.31 | ▼ 5.76% |
| RXST | RxSight, Inc. | USD 6.38 | ▼ 9.32% |
| DSGN | Design Therapeutics, Inc. | USD 15.14 | ▼ 2.51% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:05 UTC. This page is informational and not investment advice.